Rituximab as a Treatment for Limbic Encephalitis Associated with Leucine-Rich Glioma Inactivated 1: A Case Report and Literature Review
Leucine-rich glioma-inactivated-1 (LGI1) protein antibody-associated limbic encephalitis (LE) is a treatable autoimmune disease. This report is about the administration of rituximab in two patients with LGI1 antibody-associated LE. Both patients had progressive confusion, behavioral alteration, memo...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Third Party Medicine International Publishing Group Co. Limited
2019-04-01
|
| Series: | Journal of International Translational Medicine |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.11910/2227-6394.2019.07.01.15 |